Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01528670 : Monitoring of Patients Treated With Particle Therapy Using Positron-Emission-Tomography (PET): The MIRANDA Study
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria

- The patient is treated at the Heidelberger Ionenstrahl Therapiezentrum (HIT) with
protons or carbon ions.

- During the radiotherapeutic treatment patient positioning is verified using validated
radiological imaging such as cone beam CT, X-ray or conventional CT
(Reference-Imaging as described above).

- The patient is at least 18 years of age and is able to give informed consent.

- The patient has been informed about the aims and the content of the study.

Exclusion Criteria

- No informed consent to take part in the study.

- Medical reasons that impair the patients from being in the supine position for the
data acquisition time, e.g. pain.

- Non-compliance of the patient.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01528670      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740